Journal articles: 'Cervix uteri'

1

Hilgarth, M. "Arbeitsgemeinschaft Cervix uteri." Archives of Gynecology 238, no. 1-4 (September 1985): 18–21. http://dx.doi.org/10.1007/bf02429914.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Kaplan, Yu D., and T. N. Zakharenkova. "The Positional Test in Transvaginal Ultrasound in Women with the Physiological Course of Pregnancy." Health and Ecology Issues, no. 1 (March 28, 2019): 14–20. http://dx.doi.org/10.51523/2708-6011.2019-16-1-3.

Full text

Abstract:

Objective: to assess and describe the characteristics of the changes in the cervix uteri according to the data of transvaginal ultrasound conducted in lying and standing body positions in women with the physiological course of pregnancy. Material and methods. Dynamic transvaginal ultrasound of the cervix uteri was performed in two body positions (lying and standing) in 30 women with the physiological course of pregnancy and subsequent urgent labor. Results. The changes in the length of the isthmic and cervical region occur due to different anatomical segments, at different time and at different velocity. The changes in the utero-cervical angle related to the changes of body positions at the term of 28 weeks of gestation are associated with the formation of the lower segment and redistribution of pressure on it by the presenting part of the fetus. Shortly before birth, the cervix uteri is centralized. The changes in body positions of patients does not lead to significant changes in the frequency of occurrence of T- and Y-shaped internal os. Conclusion . The reference values of the parameters of the cervix uteri found by transvaginal ultrasound in the standing position were revealed and described in the women with the physiological course of pregnancy.

APA, Harvard, Vancouver, ISO, and other styles

3

Einhorn, Nina. "Cervical Cancer (Cervix Uteri)." Acta Oncologica 35, sup7 (January 1996): 75–80. http://dx.doi.org/10.3109/02841869609101666.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Horn, L. C., and K. Klostermann. "Präkanzerosen der Cervix uteri." Der Pathologe 32, S2 (September 11, 2011): 242–54. http://dx.doi.org/10.1007/s00292-011-1517-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Hilgarth, M. "Lasertherapie der Cervix Uteri." Archives of Gynecology and Obstetrics 254, no. 1-4 (December 1993): 1000–1004. http://dx.doi.org/10.1007/bf02266276.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Lakkis, Najla A., Mona H. Osman, and Reem M. Abdallah. "Cervix Uteri Cancer in Lebanon: Incidence, Temporal Trends, and Comparison to Countries From Different Regions in the World." Cancer Control 29 (January 2022): 107327482110686. http://dx.doi.org/10.1177/10732748211068634.

Full text

Abstract:

Background Invasive cervix uteri cancer is the fourth most common malignancy in women globally. This study investigates the incidence and trends of cervix uteri cancer in Lebanon, a country in the Middle East, and compares these rates to regional and global ones. Methods Data on cervix uteri were obtained from the Lebanese national cancer registry for the currently available years 2005 to 2016. The calculated age-standardized incidence and age-specific rates were expressed as per 100,000 population. Results From 2005 to 2016, cervix uteri cancer was the tenth most common cancer among women. Its age-standardized incidence rate fluctuated narrowly between 3.5 and 5.7 per 100,000, with the lowest rate in 2013 and the highest rate in 2012. The age-specific incidence rate had 2 peaks, the highest peak at age group 70–74 years and the second at age group 50–59 years. The annual percent change (+.05%) showed a non-statistically significant trend of increase. The age-standardized incidence rate of cervix uteri cancer in Lebanon was comparable to that of the Western Asia region that has the lowest incidence rate worldwide. The rate was intermediate as compared to other countries in the Middle East and North Africa Region and relatively similar to the ones in Australia, North America, and some Western European countries. Conclusion The incidence rates of invasive cervix uteri are low in Lebanon. This could be attributed to the low prevalence of human papilloma virus infection and other sexually transmitted infections among Lebanese women, and the opportunistic screening practices. It is important to adopt a comprehensive approach to decrease the potential burden of cervix uteri, especially with the rising patterns of risky sexual behaviors. This includes improving awareness, enhancing access to preventive services, developing clinical guidelines, and training health care providers on these guidelines.

APA, Harvard, Vancouver, ISO, and other styles

7

Hall, V. "Malakoplakia of the cervix uteri." Journal of Obstetrics and Gynaecology 16, no. 1 (January 1996): 62. http://dx.doi.org/10.3109/01443619609028393.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Mehlhorn, G., M. W. Beckmann, and S. Ackermann. "Praktische Kolposkopie der Cervix uteri." Geburtshilfe und Frauenheilkunde 64, no. 12 (December 2004): R261—R284. http://dx.doi.org/10.1055/s-2004-830578.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Kaestner, I., A. Seeger, and K. Nilges. "Zytologische Kontrollen der Cervix uteri." Frauenheilkunde up2date 5, no. 05 (October 2011): 293–307. http://dx.doi.org/10.1055/s-0031-1283725.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Wiebe, Ericka, Lynette Denny, and Gillian Thomas. "Cancer of the cervix uteri." International Journal of Gynecology & Obstetrics 119 (September 21, 2012): S100—S109. http://dx.doi.org/10.1016/s0020-7292(12)60023-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Benedet, J. L., F. Odicino, P. Maisonneuve, U. Beller, W. T. Creasman, A. P. M. Heintz, H. Y. S. Ngan, and S. Pecorelli. "Carcinoma of the cervix uteri." International Journal of Gynecology & Obstetrics 83 (October 2003): 41–78. http://dx.doi.org/10.1016/s0020-7292(03)90115-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

QUINN, MA, JL BENEDET, F. ODICINO, P. MAISONNEUVE, U. BELLER, WT CREASMAN, APM HEINTZ, HYS NGAN, and S. PECORELLI. "Carcinoma of the Cervix Uteri." International Journal of Gynecology & Obstetrics 95 (November 2006): S43—S103. http://dx.doi.org/10.1016/s0020-7292(06)60030-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Bermudez, Adriana, Neerja Bhatla, and Eric Leung. "Cancer of the cervix uteri." International Journal of Gynecology & Obstetrics 131 (September 30, 2015): S88—S95. http://dx.doi.org/10.1016/j.ijgo.2015.06.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Schmidt, D., L. C. Horn, and F. Kommoss. "Neuroendokrine Karzinome der Cervix uteri." Der Pathologe 26, no. 4 (July 2005): 262–65. http://dx.doi.org/10.1007/s00292-005-0766-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Kozachenko, V. P. "Adenocarcinoma of the cervix uteri." Onkologiya. Zhurnal imeni P.A.Gertsena 6, no. 1 (2017): 76. http://dx.doi.org/10.17116/onkolog20176176-80.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Amna, F. A., R. Howell, and S. Raj. "Lymphoma of the cervix uteri." Case Reports 2009, sep10 1 (September 10, 2009): bcr0520091835. http://dx.doi.org/10.1136/bcr.05.2009.1835.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Schmidt, D. "Plattenepitheliale Präkanzerosen der Cervix uteri." Der Pathologe 40, no. 1 (January 18, 2019): 7–12. http://dx.doi.org/10.1007/s00292-018-0561-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Bhatla, Neerja, Daisuke Aoki, Daya Nand Sharma, and Rengaswamy Sankaranarayanan. "Cancer of the cervix uteri." International Journal of Gynecology & Obstetrics 143 (October 2018): 22–36. http://dx.doi.org/10.1002/ijgo.12611.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Appelbaum, Alan H., Mehran Tirandaz, Giuseppe Ricci, and Roberto Levi D’Ancona. "Alignment of the Cervix with the Vagina in Uterine Retroversion: A Possible Risk Factor in Uterine Prolapse." Diagnostics 12, no. 6 (June 9, 2022): 1428. http://dx.doi.org/10.3390/diagnostics12061428.

Full text

Abstract:

Multiple observational studies have found an association of uterine prolapse with uterine retroversion. Mechanisms proposed to explain this apparent association assume that the cervix of a retroverted uterus will usually insert at the apex of the vagina, with resultant alignment of the cervix with the vagina. The angle of the axis of the cervix with the axis of the vagina was measured by two readers on 323 sagittal pelvic MRI scans and sagittal reconstructions of pelvic CT scans performed for clinical purposes. One reader observed and recorded the anatomic relations of the uterus that differed by insertion site and version: 44 of 49 retroverted uteri (89.8%) inserted at the vaginal apex, and 13 of 274 anteverted uteri (4.7%) inserted at the vaginal apex. This difference was found to be statistically significant (p < 0.05) by the Chi square test. The urinary bladder, vaginal walls, and rectum were inferiorly related to anteriorly inserted anteverted uteri. Only the vaginal lumen and the rectum at a shallow oblique angle were inferiorly related to apically inserted retroverted uteri. Most retroverted uteri insert at the apex of the vagina. Apically inserted retroverted uteri appear to receive less support from adjacent structures than anteriorly inserted anteverted uteri.

APA, Harvard, Vancouver, ISO, and other styles

20

Uzhegova, Z. A., O. R. Grigoryan, and E. N. Andreeva. "Endocrine aspects of the pathogenesis of cancer of the cervix uteri. New possibilities of primary prophylaxis." Problems of Endocrinology 55, no. 3 (June 15, 2009): 48–53. http://dx.doi.org/10.14341/probl200955348-53.

Full text

Abstract:

The review gives updates on the pathogenesis of background, precancer, and cancer of the cervix uteri. Epidemiological and molecular biological studies have established that human papillomavirus infection is the most important factor of carcinogenesis of the cervix uteri. The impact of reproductive dysfunction on the development of cervical pathology has been assessed and a possible mechanism of involvement of sex steroids in carcinogenesis assumed.

APA, Harvard, Vancouver, ISO, and other styles

21

Makarewicz, R., and G. Drewa. "A possible application of cathepsin B activity determination for estimating the spread of the cervix uteri carcinoma." Acta Biochimica Polonica 43, no. 3 (September 30, 1996): 521–24. http://dx.doi.org/10.18388/abp.1996_4486.

Full text

Abstract:

The value of cathepsin B activity determination for evaluation of the extent of disease was investigated in 98 patients with the cervix uteri carcinoma and 25 women with cervix uteri dysplasia. The measurements were performed before treatment. Cathepsin B activity was estimated in serum using Z-Phe-Arg-NMec, and in tumor tissue using Z-Arg-Arg-pNA . HCl as substrates. The mean activity of the enzyme increased both in serum and tumor tissue with progression of neoplastic disease and was dependent on the clinical stage of cervical carcinoma. It should be stressed, however, that among the patients with the clinically observed early stage of the disease, higher cathepsin B activity was observed in those in whom metastases to pelvic lymph nodes were detected than in those in whom the disease was limited to cervix uteri.

APA, Harvard, Vancouver, ISO, and other styles

22

Parulekar, S. G., and R. Kiwi. "Dynamic incompetent cervix uteri. Sonographic observations." Journal of Ultrasound in Medicine 7, no. 9 (September 1988): 481–85. http://dx.doi.org/10.7863/jum.1988.7.9.481.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Rath-Wolfson, Lea, Rumelia Koren, Aliza Amiel, Joseph Pardo, and Rivka Gal. "The ???Female Prostate??? in Cervix Uteri." Applied Immunohistochemistry 6, no. 1 (1998): 50–53. http://dx.doi.org/10.1097/00022744-199803000-00009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Z??me??n??k, Michal. "The "Female Prostate" in Cervix Uteri." Applied Immunohistochemistry 6, no. 3 (1998): 173. http://dx.doi.org/10.1097/00022744-199809000-00013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Gal, R. "The "Female Prostate" in Cervix Uteri." Applied Immunohistochemistry 6, no. 3 (1998): 173. http://dx.doi.org/10.1097/00022744-199809000-00014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Ito, Hisao, Naomi Sasaki, Kazuyasu Miyagawa, and Eiichi Tahara. "BIZARRE LEIOMYOBLASTOMA OF THE CERVIX UTERI." Pathology International 36, no. 11 (November 1986): 1737–45. http://dx.doi.org/10.1111/j.1440-1827.1986.tb02237.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Boldt, C., R. Lehmann, R. Osmers, and K. F. Bürrig. "Primäres malignes Melanom der Cervix uteri." Der Pathologe 24, no. 3 (February 12, 2003): 226–35. http://dx.doi.org/10.1007/s00292-002-0596-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Güth, U., and G. Singer. "Ektopes Prostatagewebe in der Cervix uteri." Der Pathologe 28, no. 4 (June 30, 2007): 291–93. http://dx.doi.org/10.1007/s00292-006-0874-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Lax, S. F., L. C. Horn, and T. Löning. "Kategorisierung der Tumoren der Cervix uteri." Der Pathologe 37, no. 6 (October 21, 2016): 573–84. http://dx.doi.org/10.1007/s00292-016-0247-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Devesa, Susan S., John L. Young, Louise A. Brinton, and Joseph F. Fraumeni. "Recent trends in cervix uteri cancer." Cancer 64, no. 10 (November 15, 1989): 2184–90. http://dx.doi.org/10.1002/1097-0142(19891115)64:10<2184::aid-cncr2820641034>3.0.co;2-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Djurdjevic, Predrag, Zeljko Todorovic, Danijela Jovanovic, Ivan Cekerevac, Ljiljana Novkovic, Slobodanka Mitrovic, Vesna Cemerikic, Vladimir Otasevic, and Darko Antic. "Blastic plasmacytoid dendritic cell neoplasm of the uterus." Srpski arhiv za celokupno lekarstvo 148, no. 9-10 (2020): 602–5. http://dx.doi.org/10.2298/sarh191111027d.

Full text

Abstract:

Introduction. Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and very aggressive hematological malignancy derived from precursor of the plasmacytoid dendritic cell. We present a case with cervix uteri involvement without skin lesions, which is, to the best of our knowledge, the first case of BPDCN localized in the cervix. Case outline. A 66-year-old previously healthy women initially presented with a four-week history of vaginal bleeding. Gynecologic examination revealed a tumorous bleeding formation on cervix uteri. Except paleness of the skin, physical examination results were normal. Complete blood counts showed anemia and thrombocytopenia. Computed tomography scans showed an expansive tumorous formation at the level of the isthmus and cervix uteri, 60 ? 42 mm in size. Cervical biopsy was done and final pathohistological diagnosis was BPDCN. Karyotype analysis results from the bone marrow aspiration specimen demonstrated tetrasomy of chromosome 2 and monosomy of chromosome 16. The patient did not accept treatment and died two months after the initial diagnosis was established. Conclusion. Attributes such as aggressive clinical course of BPDCN, demonstrated unusual localization, infrequency, and the absence of consensus about standard treatment options, demand constructive clinical reasoning and tight cooperation between medical professionals of various fields.

APA, Harvard, Vancouver, ISO, and other styles

32

Höhn, Anne Kathrin, Christine E. Brambs, Grit Gesine Ruth Hiller, Doris May, Elisa Schmoeckel, and Lars-Christian Horn. "2020 WHO Classification of Female Genital Tumors." Geburtshilfe und Frauenheilkunde 81, no. 10 (October 2021): 1145–53. http://dx.doi.org/10.1055/a-1545-4279.

Full text

Abstract:

AbstractThe 2020 WHO classification is focused on the distinction between HPV-associated and HPV-independent squamous cell carcinoma of the lower female genital organs. Differentiating according to HPV association does not replace the process of grading; however, the WHO classification does not recommend any specific grading system. VIN are also differentiated according to whether they are HPV(p16)-associated. HPV-independent adenocarcinoma (AC) of the cervix uteri has an unfavorable prognosis. Immunohistochemical p16 expression is considered to be a surrogate marker for HPV association. HPV-associated AC of the cervix uteri is determined using the prognostically relevant Silva pattern.

APA, Harvard, Vancouver, ISO, and other styles

33

Palaoro, LuisAlberto, Anabela Angeleri, Sardi-Segovia Melba, Fernando Guerra, Marta Palamas, and AdrianaEsther Rocher. "Urothelial cells in smears from cervix uteri." Journal of Cytology 29, no. 1 (2012): 41. http://dx.doi.org/10.4103/0970-9371.93220.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Bhatla, Neerja, Daisuke Aoki, Daya Nand Sharma, and Rengaswamy Sankaranarayanan. "Cancer of the cervix uteri: 2021 update." International Journal of Gynecology & Obstetrics 155, S1 (October 2021): 28–44. http://dx.doi.org/10.1002/ijgo.13865.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Agnarsdóttir, Margrét, Lennart Hahn, Ulla Sellgren, and Roger Willén. "Malacoplakia of the cervix uteri and vulva." Acta Obstetricia et Gynecologica Scandinavica 83, no. 2 (January 2004): 214–16. http://dx.doi.org/10.1080/j.0001-6349.2004.077c.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Agnarsdóttir, Margrét, Lennart Hahn, Ulla Sellgren, and Roger Willén. "Malacoplakia of the cervix uteri and vulva." Acta Obstetricia et Gynecologica Scandinavica 83, no. 2 (February 2004): 214–16. http://dx.doi.org/10.1111/j.0001-6349.2004.077c.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

SAGHER, F., B. BERCOVICI, and R. ROMEM. "Nikolsky sign on cervix uteri in pemphigus." British Journal of Dermatology 90, no. 4 (July 29, 2006): 407–11. http://dx.doi.org/10.1111/j.1365-2133.1974.tb06425.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Wagner, JK, and E. Keil. "Das maligne Melanom der Cervix uteri (Kasuistik)." Geburtshilfe und Frauenheilkunde 77, no. 02 (March 6, 2017): 192–200. http://dx.doi.org/10.1055/s-0036-1597743.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Ismail, S. M. "Atlas of Histopathology of the Cervix Uteri." Histopathology 20, no. 1 (January 1992): 91–92. http://dx.doi.org/10.1111/j.1365-2559.1992.tb00930.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Holweg, M., A. Kopp, H. Stegner, T. Löning, and W. Jonat. "Primäres Lymphom der Cervix uteri - zwei Kasuistiken." Geburtshilfe und Frauenheilkunde 55, no. 03 (March 1995): 171–72. http://dx.doi.org/10.1055/s-2007-1022799.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Heyn, M., H. Urbanczyk, and W. Simoens. "Chorionkarzinom der Cervix uteri und zervikale Schwangerschaft." Geburtshilfe und Frauenheilkunde 53, no. 07 (July 1993): 498–500. http://dx.doi.org/10.1055/s-2007-1022922.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Fish, Charles R., and Thomas A. Gaffey. "Atlas of Histopathology of the Cervix Uteri." Mayo Clinic Proceedings 66, no. 7 (July 1991): 766. http://dx.doi.org/10.1016/s0025-6196(12)62100-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Lynge, Elsebeth. "Screening for cancer of the cervix uteri." World Journal of Surgery 13, no. 1 (January 1989): 71–78. http://dx.doi.org/10.1007/bf01671157.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Schmidt, D. "Moderne Biomarker bei Präkanzerosen der Cervix uteri." Der Pathologe 37, no. 6 (September 15, 2016): 534–41. http://dx.doi.org/10.1007/s00292-016-0231-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Kaur, Inderjit, and I. P. Singh. "Risk Factors in Cancer of Cervix Uteri." Journal of Human Ecology 3, no. 3 (July 1992): 225–28. http://dx.doi.org/10.1080/09709274.1992.11907926.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Sugimori, H., T. Iwasaka, T. Yoshimura, and N. Tsukamoto. "Zytologie des mikroinvasiven Plattenepithelkarzinoms der Cervix uteri." Gynäkologisch-geburtshilfliche Rundschau 28, no. 2 (1988): 104–6. http://dx.doi.org/10.1159/000270625.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Bollmann, R. "DNA-Zytometrie bei Dysplasien der Cervix uteri." Zentralblatt für Gynäkologie 123, no. 4 (2001): 206–10. http://dx.doi.org/10.1055/s-2001-14776.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Wasef, W. R., J. K. Roberts, and G. R. Dixon. "Primary malignant melanoma of the cervix uteri." Journal of Obstetrics and Gynaecology 19, no. 6 (January 1999): 673–74. http://dx.doi.org/10.1080/01443619964094.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Wright, Kelly Nicole, Ogochukwu Okpala, and Marc R. Laufer. "Obstructed uteri with a cervix and vagina." Fertility and Sterility 95, no. 1 (January 2011): 290.e17–290.e19. http://dx.doi.org/10.1016/j.fertnstert.2010.05.051.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Stickelmann, P., O. Bauer, W. Windemuth, and D. Krebs. "Hochmalignes Non-Hodgkin-Lymphom der Cervix uteri." Archives of Gynecology and Obstetrics 245, no. 1-4 (July 1989): 553–54. http://dx.doi.org/10.1007/bf02417423.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Journal articles on the topic 'Cervix uteri'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles